Design, synthesis and evaluation of lantadene A congener with hydroxyl functionality in ring A as an antitumour agent

Natural Product Research
Manu SharmaNeetika Sharma

Abstract

Pentacyclic triterpenoid lantadene A congener with hydroxyl functionality in ring A was designed and synthesised on the basis of enhancement of polarity and bioactivity. The new synthesised compound 22β-angeloyloxy-methyl-2-hydroxy-3-oxoolean-1,12-dien-28-oate (6) was screened for cytotoxicity against human cancer cell lines (HL-60, HeLa, Colon 502713 and A-549) and showed a better cytotoxicity than the parent compound (p<0.05). Further, compound 6 was screened for in vivo antitumour activity in a two-stage squamous cell carcinogenesis model, using female Swiss albino mice. Compound 6 showed a better tumour inhibition profile than the parent compound. Compound 6 also exhibited a marked decrease in protein expression of activator protein-1 (c-jun), nuclear factor-kappa B (p65) and p55. The results inferred that an increase in polarity of the lead molecule not only increased the antitumour activity but also reduced the dose, which may be linked to the deregulation of the abovementioned molecular targets, and warrants further optimisation of the structure to make it a drug-like candidate.

References

Jan 1, 1994·Annual Review of Cell Biology·U SiebenlistK Brown
Feb 7, 1998·The Journal of Biological Chemistry·M L AgarwalG R Stark
Apr 30, 1998·Advances in Cancer Research·M R Mowat
Dec 23, 1998·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Y ShuklaN K Mehrotra
Feb 26, 2000·Carcinogenesis·M B Sporn, N Suh
Jul 14, 2001·Fitoterapia·E L Ghisalberti
May 4, 2002·Nature Cell Biology·Eitan Shaulian, Michael Karin
Aug 23, 2002·Nature·M J Rosovitz, Stephen H Leppla
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karim AsehnouneEdward Abraham
Nov 27, 2004·Journal of Cell Science·Jochen HessMarina Schorpp-Kistner
May 19, 2007·Chemistry & Biodiversity·Manu SharmaJaswant Singh
Jun 17, 2008·Journal of Natural Products·M SharmaM P Bansal
Nov 1, 1991·Journal of Chemical Ecology·O P SharmaP D Sharma

❮ Previous
Next ❯

Citations

Dec 8, 2015·BMC Complementary and Alternative Medicine·Looi Ting YeongNorhafizah Mohtarrudin
May 7, 2013·European Journal of Medicinal Chemistry·Navin K TailorManu Sharma
Mar 7, 2020·Natural Product Research·Masateru OnoToshihiro Nohara

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.